Yogesh N V Reddy1, Masaru Obokata1, Frederik H Verbrugge2, Grace Lin1, Barry A Borlaug3. 1. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota. 2. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota; Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium. 3. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: borlaug.barry@mayo.edu.
Abstract
BACKGROUND: Paroxysmal and permanent atrial fibrillation (AF) are common in heart failure with preserved ejection fraction (HFpEF). OBJECTIVES: This study sought to determine the implications of left atrial (LA) myopathy and dysrhythmia across the spectrum of AF burden in HFpEF. METHODS: Consecutive patients with HFpEF (n = 285) and control subjects (n = 146) underwent invasive exercise testing and echocardiographic assessment of cardiac structure, function, and pericardial restraint. RESULTS: Patients with HFpEF were categorized into stages of AF progression: 181 (65%) had no history of AF, 49 (18%) had paroxysmal AF, and 48 (17%) had permanent AF. Patients with permanent AF were more congested with greater pulmonary vascular disease and lower cardiac output. LA volumes increased, while LA compliance, LA reservoir strain, and right ventricular function decreased with increasing AF burden. The presence of permanent AF was characterized by a distinct pathophysiology, with greater total heart volume caused by atrial dilatation, leading to elevated filling pressures through heightened pericardial restraint. Survival decreased with increasing AF burden. Ten-year progression to permanent AF was common, particularly in paroxysmal AF (52%), and the likelihood of AF progression increased with higher AF stage, poorer LA compliance, and lower LA strain. CONCLUSIONS: LA compliance and mechanics progressively decline with increasing AF burden in HFpEF, increasing risk for new onset AF and progressive AF. These changes promote development of a unique phenotype of HFpEF characterized by heightened ventricular interaction, right heart failure, and worsening pulmonary vascular disease. Further study is required to identify therapeutic interventions targeting LA myopathy to improve outcomes in HFpEF.
BACKGROUND: Paroxysmal and permanent atrial fibrillation (AF) are common in heart failure with preserved ejection fraction (HFpEF). OBJECTIVES: This study sought to determine the implications of left atrial (LA) myopathy and dysrhythmia across the spectrum of AF burden in HFpEF. METHODS: Consecutive patients with HFpEF (n = 285) and control subjects (n = 146) underwent invasive exercise testing and echocardiographic assessment of cardiac structure, function, and pericardial restraint. RESULTS:Patients with HFpEF were categorized into stages of AF progression: 181 (65%) had no history of AF, 49 (18%) had paroxysmal AF, and 48 (17%) had permanent AF. Patients with permanent AF were more congested with greater pulmonary vascular disease and lower cardiac output. LA volumes increased, while LA compliance, LA reservoir strain, and right ventricular function decreased with increasing AF burden. The presence of permanent AF was characterized by a distinct pathophysiology, with greater total heart volume caused by atrial dilatation, leading to elevated filling pressures through heightened pericardial restraint. Survival decreased with increasing AF burden. Ten-year progression to permanent AF was common, particularly in paroxysmal AF (52%), and the likelihood of AF progression increased with higher AF stage, poorer LA compliance, and lower LA strain. CONCLUSIONS: LA compliance and mechanics progressively decline with increasing AF burden in HFpEF, increasing risk for new onset AF and progressive AF. These changes promote development of a unique phenotype of HFpEF characterized by heightened ventricular interaction, right heart failure, and worsening pulmonary vascular disease. Further study is required to identify therapeutic interventions targeting LA myopathy to improve outcomes in HFpEF.
Authors: Thomas M Gorter; Masaru Obokata; Yogesh N V Reddy; Vojtech Melenovsky; Barry A Borlaug Journal: Eur Heart J Date: 2018-08-07 Impact factor: 29.983
Authors: Maximilian von Roeder; Karl-Philipp Rommel; Johannes Tammo Kowallick; Stephan Blazek; Christian Besler; Karl Fengler; Joachim Lotz; Gerd Hasenfuß; Christian Lücke; Matthias Gutberlet; Gerhard Schuler; Andreas Schuster; Philipp Lurz Journal: Circ Cardiovasc Imaging Date: 2017-04 Impact factor: 7.792
Authors: Fernando Telles; Shane Nanayakkara; Shona Evans; Hitesh C Patel; Justin A Mariani; Donna Vizi; Jeremy William; Thomas H Marwick; David M Kaye Journal: Eur J Heart Fail Date: 2019-01-16 Impact factor: 15.534
Authors: Barak Zafrir; Lars H Lund; Cecile Laroche; Frank Ruschitzka; Maria G Crespo-Leiro; Andrew J S Coats; Stefan D Anker; Gerasimos Filippatos; Petar M Seferovic; Aldo P Maggioni; Manuel De Mora Martin; Lech Polonski; José Silva-Cardoso; Offer Amir Journal: Eur Heart J Date: 2018-12-21 Impact factor: 29.983
Authors: Masaru Obokata; Yogesh N V Reddy; Sanjiv J Shah; David M Kaye; Finn Gustafsson; Gerd Hasenfuβ; Elke Hoendermis; Sheldon E Litwin; Jan Komtebedde; Carolyn Lam; Daniel Burkhoff; Barry A Borlaug Journal: J Am Coll Cardiol Date: 2019-11-26 Impact factor: 24.094
Authors: Dipak Kotecha; Carolyn S P Lam; Dirk J Van Veldhuisen; Isabelle C Van Gelder; Adriaan A Voors; Michiel Rienstra Journal: J Am Coll Cardiol Date: 2016-11-15 Impact factor: 24.094
Authors: Julia Mascherbauer; Caroline Zotter-Tufaro; Franz Duca; Christina Binder; Matthias Koschutnik; Andreas A Kammerlander; Stefan Aschauer; Diana Bonderman Journal: JACC Heart Fail Date: 2017-10-11 Impact factor: 12.035
Authors: Yogesh N V Reddy; Masaru Obokata; Aaron D Jones; Gregory D Lewis; Sanjiv J Shah; Omar F Abouezzedine; Marat Fudim; Brooke Alhanti; Lynne W Stevenson; Margaret M Redfield; Barry A Borlaug Journal: J Card Fail Date: 2020-08-19 Impact factor: 5.712
Authors: Chakradhari Inampudi; Daniel Silverman; Marc A Simon; Peter J Leary; Kavita Sharma; Brian A Houston; Jean-Luc Vachiéry; Francois Haddad; Ryan J Tedford Journal: Chest Date: 2021-08-12 Impact factor: 9.410
Authors: Francesco Bandera; Anita Mollo; Matteo Frigelli; Giulia Guglielmi; Nicoletta Ventrella; Maria Concetta Pastore; Matteo Cameli; Marco Guazzi Journal: Front Cardiovasc Med Date: 2022-01-13
Authors: Frederik H Verbrugge; Yogesh N V Reddy; Zachi I Attia; Paul A Friedman; Peter A Noseworthy; Francisco Lopez-Jimenez; Suraj Kapa; Barry A Borlaug Journal: Circ Heart Fail Date: 2021-12-16 Impact factor: 8.790